Imitation is the sincerest form of flattery; that is, unless the imitation is of a product produced by a multi billion-dollar industry. Then, imitation has the potential to involve intellectual property litigation. For the pharmaceutical industry, the majority of intellectual property litigation...

The present framework has incorporated the TRIPs agreement whose major provisions are based so as to protect the interest of western countries as well as to protect their industrial as well as economic interest in the developing and least developed countries. This paper is an attempt to analyze...

Pharmaceutical prices are widely dispersed across countries with comparable quality standards. We study two elements of this dispersion; non-tariff barriers and buyer bargaining power. Under monopoly, generic drug prices are 3-4 times higher in the United States. With 6 or more competitors,...